A MACHINE-BASED LEARNING MODEL FOR RECURRENCE PREDICTION AND TIMING AFTER ENDOSCOPIC ERADICATION THERAPY FOR BARRETT&apos;S ESOPHAGUS

Inflammatory Bowel Disease

Development and validation of a predictive model for early failure of biological therapy in perianal fistulizing Crohn's disease based on three-dimensional transrectal ultrasound

Inflamm Bowel Dis

Ding SS, Liu C, Zhang GQ, Ren WW, Zhao H, Zhang Q, Yin HQ, Sun LP, Xu HX

doi: 10.1093/ibd/izag048

Esophagus Diseases

AGA Clinical Practice Guideline on Surveillance of Barrett's Esophagus

Gastroenterology

Wani S, Zhou MJ, Sawas T, Rubenstein JH, Eluri S, Leiman DA, Sultan S, Singh S, Inadomi J, Thrift AP, Katzka DA, Davitkov P

doi: 10.1053/j.gastro.2025.09.012

Helicobacter Pylori

Real-Time Prediction of Helicobacter pylori Infection Using a Deep Learning Model During Esophagogastroduodenoscopy: A Prospective Multicenter Study

Helicobacter

Yan-Dong L, Huo-Gen W, Xue-Hui Y, Xiao-Jin L, Shu-Wen Z, Yue-Wen L, Jiang-Ping Y, Yuan-Han Z, Shi W

doi: 10.1111/hel.70078

Gastrointestinal CancerHepatitisHepatology

Curative treatment is feasible for recurrent hepatocellular carcinoma regardless of recurrence pattern after hepatitis C virus eradication with interferon-free direct-acting antiviral therapy

BMC Gastroenterol

Hagiwara S, Matsubara T, Omaru N, Okai N, Komeda Y, Ueshima K, Minami Y, Takita M, Morita M, Chishina H, Yoshida A, Nishida N, Kudo M

doi: 10.1186/s12876-026-05006-x

Inflammatory Bowel Disease

Retention of the ileocolic pedicle correlates with higher postoperative endoscopic recurrence risk in Crohn's disease ileocolic resection

J Crohns Colitis

Zhang C, Liu G, Bi J, Fu J, Tu Q, Zhou C, Duan M, Cao L, Peng L, Ding Z, Li Y

doi: 10.1093/ecco-jcc/jjag116

Further Publications

Five-Year Unified Risk Prediction Model for Gastric and Esophageal Cancer Based on Nationwide Health Check-Up Data in Japan: J-GESS Score

J Gastroenterol Hepatol

Watanabe K, Fukuda S, Kubota D, Yamamichi N, Takahashi Y, Watanabe Y, Adachi K, Ishimura N, Koike T, Sugawara H, Asanuma K, Abe Y, Kon T, Ihara E, Haraguchi K, Otsuka Y, Yoshimura R, Iwaya Y, Okamura T, Manabe N, Horiuchi A, Matsumoto M, Onochi K, Takahashi S, Yoshida T, Shimodaira Y, Iijima K

doi: 10.1111/jgh.70409

Helicobacter Pylori

Efficacy and Safety of Tegoprazan-Based Dual, Triple, and Quadruple Therapies in First-Line Helicobacter pylori Eradication: A Prospective Randomized Controlled Trial

Helicobacter

Zhu YC, Li K, Sun A, Lin S, Zhang J, Meng S, Xia X, Gao H, Lin J, Jiang W

doi: 10.1111/hel.70147

Further Publications

Effect of Mirikizumab on Clinical and Endoscopic Outcomes Based on Prior Advanced Therapy Failure in Patients With Moderately to Severely Active Ulcerative Colitis

United European Gastroenterol J

Hart A, Navabi S, D'Haens G, Matsuoka K, Martín-Arranz MD, Atreya R, Samaan KH, Dhesi E, Redondo I, Zhu B, Paulissen J, Zaremba-Pechmann L, Baygani S, Limdi J, Laharie D, Danese S

doi: 10.1002/ueg2.70214

Helicobacter Pylori

Efficacy and Safety of Fexuprazan-Based Modified High-Dose Dual Therapy for Helicobacter pylori Eradication: A Randomized Clinical Trial

Helicobacter

Ahn JY, Shim KN, Park JH, Kim SG, Kim JH, Moon JS, Youn YH, Kim JJ

doi: 10.1111/hel.70146

Related content

Development and validation of a predictive model for early failure of biological therapy in perianal fistulizing Crohn's disease based on three-dimensional transrectal ultrasound

AGA Clinical Practice Guideline on Surveillance of Barrett's Esophagus

Real-Time Prediction of Helicobacter pylori Infection Using a Deep Learning Model During Esophagogastroduodenoscopy: A Prospective Multicenter Study

Curative treatment is feasible for recurrent hepatocellular carcinoma regardless of recurrence pattern after hepatitis C virus eradication with interferon-free direct-acting antiviral therapy

Retention of the ileocolic pedicle correlates with higher postoperative endoscopic recurrence risk in Crohn's disease ileocolic resection

Five-Year Unified Risk Prediction Model for Gastric and Esophageal Cancer Based on Nationwide Health Check-Up Data in Japan: J-GESS Score

Efficacy and Safety of Tegoprazan-Based Dual, Triple, and Quadruple Therapies in First-Line Helicobacter pylori Eradication: A Prospective Randomized Controlled Trial

Effect of Mirikizumab on Clinical and Endoscopic Outcomes Based on Prior Advanced Therapy Failure in Patients With Moderately to Severely Active Ulcerative Colitis

Efficacy and Safety of Fexuprazan-Based Modified High-Dose Dual Therapy for Helicobacter pylori Eradication: A Randomized Clinical Trial